Literature DB >> 33368053

Anti-glycin-receptor antibody related stiff-person syndrome under treatment with an immune checkpoint inhibitor.

Nils Schröter1, Cornelius Weiller2, Sebastian Rauer2, Cornelius F Waller3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33368053      PMCID： PMC7880930          DOI： 10.1007/s00415-020-10351-2

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  4 in total

1.  Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.

Authors:  Julie R Brahmer; Christina Lacchetti; Bryan J Schneider; Michael B Atkins; Kelly J Brassil; Jeffrey M Caterino; Ian Chau; Marc S Ernstoff; Jennifer M Gardner; Pamela Ginex; Sigrun Hallmeyer; Jennifer Holter Chakrabarty; Natasha B Leighl; Jennifer S Mammen; David F McDermott; Aung Naing; Loretta J Nastoupil; Tanyanika Phillips; Laura D Porter; Igor Puzanov; Cristina A Reichner; Bianca D Santomasso; Carole Seigel; Alexander Spira; Maria E Suarez-Almazor; Yinghong Wang; Jeffrey S Weber; Jedd D Wolchok; John A Thompson
Journal:  J Clin Oncol       Date:  2018-02-14       Impact factor: 44.544

Review 2.  Stiff-person syndrome: insights into a complex autoimmune disorder.

Authors:  José Fidel Baizabal-Carvallo; Joseph Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-12-15       Impact factor: 10.154

Review 3.  The PD-1 pathway in tolerance and autoimmunity.

Authors:  Loise M Francisco; Peter T Sage; Arlene H Sharpe
Journal:  Immunol Rev       Date:  2010-07       Impact factor: 12.988

Review 4.  SPS: Understanding the complexity.

Authors:  Rima El-Abassi; Michael Y Soliman; Nicole Villemarette-Pittman; John D England
Journal:  J Neurol Sci       Date:  2019-07-17       Impact factor: 3.181
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.